New study shows that AI can predict lung cancer from digitized patient tissue samples rapidly and with a high degree of ...
Hetronifly in combination with chemotherapy was shown to improve survival of patients with extensive stage small cell lung ...
Pfizer is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug ...
Many in the country music world have been following along and sending support as Joshua Ray Walker shares updates on his ...
Treatment of non-small cell lung cancer (NSCLC) depends on the stage you're in and can include chemotherapy, surgery, ...
Observed annually on September 25th, this global health awareness day highlights the importance of lung health. Here are 8 ...
HANSIZHUANG ® (serplulimab) was the first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC – ...
This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West ...
For patients with limited-stage small cell lung cancer, adjuvant therapy with durvalumab leads to significantly longer ...
“They suspected lung cancer,” said lung cancer awareness advocate Matthew Koebbe. “We did a biopsy, and confirmed that, yes, ...
In head-to-head clinical trial, Chinese firm Akeso’s ivonescimab beat top-selling drug pembrolizumab sold as Keytruda by Merck. Ivonescimab reduced risk of tumour progression by 49%.
Joshua Ray Walker let fans know this week that Thursday is slated to be a big day for him in his battle against cancer. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback